{
  "resourceType": "ValueSet",
  "id": "detectedissue-category",
  "meta": {
    "lastUpdated": "2019-11-01T09:29:23.356+11:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset"
    ]
  },
  "text": {
    "status": "generated",
    "div": "\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\u003ch2\u003eDetected Issue Category\u003c/h2\u003e\u003cdiv\u003e\u003cp\u003eKinds of issues or contraindications, such as \u0027drug-drug interaction\u0027, \u0027duplicate therapy\u0027, etc.\u003c/p\u003e\n\u003c/div\u003e\u003cp\u003eThis value set includes codes from the following code systems:\u003c/p\u003e\u003cul\u003e\u003cli\u003eInclude codes from \u003ca href\u003d\"v3/ActCode/cs.html\"\u003e\u003ccode\u003ehttp://terminology.hl7.org/CodeSystem/v3-ActCode\u003c/code\u003e\u003c/a\u003e where concept  is-a  \u003ca href\u003d\"v3/ActCode/cs.html#v3-ActCode-_AdministrationDetectedIssueCode\"\u003e_AdministrationDetectedIssueCode\u003c/a\u003e\u003c/li\u003e\u003cli\u003eInclude codes from \u003ca href\u003d\"v3/ActCode/cs.html\"\u003e\u003ccode\u003ehttp://terminology.hl7.org/CodeSystem/v3-ActCode\u003c/code\u003e\u003c/a\u003e where concept  is-a  \u003ca href\u003d\"v3/ActCode/cs.html#v3-ActCode-_ActSuppliedItemDetectedIssueCode\"\u003e_ActSuppliedItemDetectedIssueCode\u003c/a\u003e\u003c/li\u003e\u003cli\u003eInclude codes from \u003ca href\u003d\"v3/ActCode/cs.html\"\u003e\u003ccode\u003ehttp://terminology.hl7.org/CodeSystem/v3-ActCode\u003c/code\u003e\u003c/a\u003e where concept  is-a  \u003ca href\u003d\"v3/ActCode/cs.html#v3-ActCode-_SupplyDetectedIssueCode\"\u003e_SupplyDetectedIssueCode\u003c/a\u003e\u003c/li\u003e\u003c/ul\u003e\u003c/div\u003e"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode": "cds"
    }
  ],
  "url": "http://hl7.org/fhir/ValueSet/detectedissue-category",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.4.642.3.204"
    }
  ],
  "version": "4.0.1",
  "name": "DetectedIssueCategory",
  "title": "Detected Issue Category",
  "status": "draft",
  "experimental": false,
  "date": "2019-11-01T09:29:23+11:00",
  "publisher": "FHIR Project team",
  "contact": [
    {
      "telecom": [
        {
          "system": "url",
          "value": "http://hl7.org/fhir"
        }
      ]
    }
  ],
  "description": "Kinds of issues or contraindications, such as \u0027drug-drug interaction\u0027, \u0027duplicate therapy\u0027, etc.",
  "compose": {
    "include": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode",
        "filter": [
          {
            "property": "concept",
            "op": "is-a",
            "value": "_AdministrationDetectedIssueCode"
          }
        ]
      },
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode",
        "filter": [
          {
            "property": "concept",
            "op": "is-a",
            "value": "_ActSuppliedItemDetectedIssueCode"
          }
        ]
      },
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode",
        "filter": [
          {
            "property": "concept",
            "op": "is-a",
            "value": "_SupplyDetectedIssueCode"
          }
        ]
      }
    ]
  }
}